nContact, Inc. Release: New Publication From The Valley Health System Highlights The Convergent Procedure As A "Go-To" Approach For Persistent Atrial Fibrillation Patients

Published: Mar 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C., March 12, 2014 (GLOBE NEWSWIRE) -- EP Lab Digest has published an article that highlights the critical role of comprehensive posterior ablation using the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) patients. AF is estimated to affect 5.9 million people in the U.S., with a majority of patients falling into the difficult-to-treat persistent AF population. The physicians highlight the advantages of offering a new treatment alternative, the multidisciplinary Convergent Procedure, to patients who have lived with AF for years.

Help employers find you! Check out all the jobs and post your resume.

Back to news